profit from every €100 of sales.
€0€100
Straumann
€116.00+0.00% today
+14.2% since Dec 18, 25
1-year low €82.941-year high €118.00
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay €47.98 for every €1 of profit it makes in a year.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Straumann sold, what it kept, and what it did with the cash.
Sales went from CHF 2.32 billion in 2022 to CHF 2.61 billion in 2025, with CHF 356 million of profit last year.
SalesProfit
Straumann handed back 63% of the cash it generated last year.
CHF 151M
Free cash flow 2025CHF 281M
Bought back its own sharesCHF 25M
Paid as dividendsCHF 151M
Cash vs. debtCHF 475M vs. CHF 419M
Straumann vs. similar companies
Straumann grows the slowest of these 5 and is priced in the middle for its profits.
| Company | Profit from €100 of sales | Sales growth a year | Price per €1 of profit |
|---|---|---|---|
| Straumann | 48.0× · Expensive | ||
 Intuitive Surgical | 54.6× · Expensive | ||
 EssilorLuxottica Société anonyme | 36.1× · Expensive | ||
 Becton, Dickinson and | 34.8× · Expensive | ||
 Medline | 47.9× · Expensive |
AI analysis
An AI analyst reads Straumann's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of CHF | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 2,321 | 2,277 | 2,504 | 2,605 | |
| 1,755 | 1,691 | 1,783 | 1,787 | |
| 535 | 598 | 601 | 549 | |
| 678 | 685 | 726 | 628 | |
| 435 | 246 | 388 | 356 | |
| 2.72 | 1.54 | 2.43 | 2.23 | |
| 75.6% | 74.3% | 71.2% | 68.6% | |
| 23.1% | 26.3% | 24.0% | 21.1% | |
| 18.7% | 10.8% | 15.5% | 13.7% |
Balance sheet
| In millions of CHF | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 3,373 | 3,322 | 3,619 | 3,758 |
| Cash | 696 | 410 | 375 | 475 |
| Total debt | 702 | 412 | 414 | 419 |
| Total liabilities | 1,520 | 1,483 | 1,575 | 1,593 |
| 1,852 | 1,836 | 2,040 | 2,161 | |
| – | – | – | 160 | |
| 14.1% | 17.5% | 16.6% | 12.8% | |
| 23.5% | 13.4% | 19.0% | 16.5% |
Cash flow
| In millions of CHF | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 415 | 504 | 483 | 504 | |
| 195 | 187 | 168 | 223 | |
| 220 | 317 | 316 | 281 | |
| Dividends paid | 107 | 127 | 135 | 151 |
| 7 | 27 | 28 | 25 | |
| 14 | 14 | 18 | 19 |
Valuation
- 48.0×
- –
- –
- 7.5×
- 6.6×
- 60.9×
- 27.1×
- 1.6%
- 2.1%
- 0.9%
Profitability
- 68.6%
- 21.1%
- 13.7%
- –
- 12.8%
- 15.2%
- –
- –
- –
- –
Growth
- +3.9%
- −6.4%
- –
- –
- +0.0%
Financial health
- -0.1×
- 0.19
- –
- 30.8×
- 2.21
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 19%of 958
Top 21%of 888
Bottom 24%of 600
Bottom 27%of 889
Top 46%of 987
0.9%of the share price, paid each year
On $1,000 invested$9a year at today's yield, before tax
–per share
Raised–not every year
How safe it looks
42.5% of its profit
Room to growStretchedMore than it earns: 54.0%
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
57No pass
Benjamin Graham
40No pass
Philip Fisher
44No pass
Peter Lynch
30No pass
Joel Greenblatt
10No pass
Charlie Munger
55No pass
Terry Smith
45No pass
Questions about Straumann
Is Straumann a good stock to buy?
A solid business, but the price is high. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Straumann AI analysis
What does Straumann do?
Straumann Holding AG provides tooth replacement and orthodontic solutions in Switzerland, the United States, China, Germany, Brazil, Japan, France, and internationally. It is in Medical Instruments & Supplies, based in Basel, Switzerland, with 11,319 employees.
Does Straumann pay a dividend?
Yes. At today's price the dividend is 0.9% a year, about 43% of its yearly profit. In 2025 it paid out €151 million in dividends.
Is Straumann stock halal?
Yes. Straumann passes our halal screen: its business is permitted and its debt is 2% of its market value, under the 30% limit. How we check
Who are Straumann's competitors?
The largest listed companies in the same industry are Intuitive Surgical, EssilorLuxottica Société anonyme, Becton, Dickinson and and Medline. The peers table on this page compares their profit, growth and price with Straumann's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.